Variable | Adjusted Odds Ratio (aOR) | 95% Confidence Interval (95% CI) | p value |
---|---|---|---|
INNa: < 15% | 1.08 | 0.62–1.90 | 0.78 |
Practice: in cities (versus rural areas) | 1.59 | 0.93–2.74 | 0.09 |
EPSb | 0.46 | 0.20–1.05 | 0.07 |
Higher efficacy of brand-name drug | 1.52 | 0.70–3.30 | 0.29 |
Does not believe in bioequivalence | 0.92 | 0.41–2.05 | 0.84 |
Patient request | 2.52 | 1.46–4.35 | 0.001 |
Patient comorbidity | 2.79 | 0.96–8.04 | 0.06 |
Polypharmacy | 1.00 | 0.37–2.73 | 0.99 |
Age of patient over 65 years | 2.33 | 1.03–5.30 | 0.04 |